Dynamics of pain syndrome and quality of life in the application of vertebroplasty in patients with vertebral fractures against osteoporosis

Authors

  • A.T. Stashkevych SІ "Institute of traumatology and orthopedics of National academy of medical sciences of Ukraine", Department of spinal surgery with spinal (neurosurgical) center, Bulvarno-Kudriavska str., 27, Kyiv, 01601, Ukraine, Ukraine https://orcid.org/0000-0002-0851-815X
  • A.V. Shevchuk SІ "Institute of traumatology and orthopedics of National academy of medical sciences of Ukraine", Department of spinal surgery with spinal (neurosurgical) center, Bulvarno-Kudriavska str., 27, Kyiv, 01601, Ukraine, Ukraine https://orcid.org/0000-0003-3829-9231
  • D.V. Uleshchenko SІ "Institute of traumatology and orthopedics of National academy of medical sciences of Ukraine", Department of spinal surgery with spinal (neurosurgical) center, Bulvarno-Kudriavska str., 27, Kyiv, 01601, Ukraine, Ukraine https://orcid.org/0000-0001-6085-3791
  • V.G. Martynenko SІ "Institute of traumatology and orthopedics of National academy of medical sciences of Ukraine", Department of spinal surgery with spinal (neurosurgical) center, Bulvarno-Kudriavska str., 27, Kyiv, 01601, Ukraine, Ukraine https://orcid.org/0000-0001-6289-3199
  • V.I. Melenko SІ "Institute of traumatology and orthopedics of National academy of medical sciences of Ukraine", Department of spinal surgery with spinal (neurosurgical) center, Bulvarno-Kudriavska str., 27, Kyiv, 01601, Ukraine, Ukraine https://orcid.org/0000-0002-7145-9957

DOI:

https://doi.org/10.26641/2307-0404.2021.1.227996

Keywords:

osteoporosis, vertebrae, vertebroplasty, fracture

Abstract

Currently, insufficient attention is being paid to an issue of the necessary anti-osteoporotic therapy after percutaneous vertebroplasty for vertebral fractures associated with osteoporosis, which leads to premature termination of medical treatment and worsening of the treatment results in this group of patients.  An objective of the research is to study the results of treatment of patients with vertebral fractures associated with osteoporosis, depending on the use of anti-osteoporotic therapy. The results of percutaneous vertebroplasty of 91 postmenopausal women aged 50-90 years, depending on the use of anti-osteoporotic therapy during the postoperative period were analysed.  An assessment was made according to the dynamics of pain syndrome using the Visual Analogue Scale (VAS), the Quality of Life Scale by J.R. Gaughen to estimate the patient's mobility and a need for pain medication. The results of the treatment were assessed 3 and 6 months after the percutaneous vertebroplasty. Bone mineral density was measured using Dual-energy X-ray absorptiometry 6 month after the treatment. Anti-osteoporotic therapy, which was prescribed for all patients comprised calcium supplements, antiresorbents and in D-hypovitaminosis – alfacalcidol or cholecalciferol. Only half of the patients followed the recommendations – 46 (50.6%), while the rest of the patients stopped the therapy in 2-3 months due to the improvement of their condition. In the main group of patients, where necessary anti-osteoporotic therapy was administered, significant reduction of pain syndrome and increase in quality of life during 3 and 6 months’ observation period were revealed. In the group of patients where prescribed anti-osteoporotic therapy was not adhered, significant reduction of pain syndrome and increase in quality of life in the observation period 3 months was revealed but deterioration in the form of pain syndrome increase and decrease in quality of life in the observation period of 6 months occurred. Effectiveness of anti-osteoporosis therapy, with regard to measuring bone mineral density can be reliably confirmed only in the main group. Intraoperative and postoperative complications occurred up to 5.5%, and generally did not require further treatment and did not affect the overall treatment result. Thus, it was revealed that to ensure a stable effect after the surgery, long-term prescription of anti-osteoporosis therapy is needed.

References

Garmish AR. [Technical features and anatomical background of choice of Percutaneous vertebroplasty for aggressive vertebral hemangiomas]. Ukrainskyi neirokhirurhichnyi zhurnal. 2003;2:78-82. Russian.

Available from: http://nbuv.gov.ua/UJRN/Unkhj_2003_2_15

Petrie A, Sabin C. [Visual Medical Statistics: A Study Guide]. Leonov VP, editor. GEOTAR-Media; 2015. p. 216. Russian.

Rudenko JeV. [Dual-energy X-ray absorptiometry – a method for the quantitative diagnosis of osteoporosis]. Novosti luchevoi diagnostiki. 1998;3:16-17. Russian. Available from: http://www.nld.by/398/stat7.htm

Francisco Aparisi. Vertebroplasty and kyphoplasty in vertebral osteoporotic fractures. Semin Musculoskelet Radiol. 2016;20(4):382-91. doi: https://doi.org/10.1055/s-0036-1592431

Hui Zhang, Caiyuan Xu, Tongxing Zhang, Zhongyu Gao, Tao Zhang. Does percutaneous vertebroplasty or balloon kyphoplasty for osteoporotic vertebral compression fractures increase the incidence of new vertebral fractu¬res? A meta-analysis. Pain Physician. 2017;20(1):13-28. doi: https://doi.org/10.36076/ppj.2017.1.E13

Kim Y-C, Bok DH, Chang H-G, Kim SW, Park MS, Oh JK, Kim J, Kim T-H. Increased sagittal vertical axis is associated with less effective control of acute pain following vertebroplasty. Bone Joint Res. 2016;11:544-51. doi: https://doi.org/10.1302/2046-3758.511

Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), ShortForm McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care & Research. 2011;63(11):240-52. doi: https://doi.org/10.1002/acr.20543

Martikos K, Greggi T, Faldini C, Vommaro F, Scarale A. Osteoporotic thoracolumbar compression frac¬tures: long-term retrospective comparison between ver¬tebroplasty and conservative treatment. Eur Spine J. 2018;27(2):244-7.

doi: https://doi.org/10.1007/s00586-018-5605-1

Buchbinder R, Johnston RV, Rischin KJ, Homik J, Jones CA, Golmohammadi K, Kallmes DF. Per¬cu¬taneous vertebroplasty for osteoporotic vertebral com¬pression fracture. Cochrane Database Syst Rev. 2018;6(11). doi: https://doi.org/10.1002/14651858.CD006349.pub3

Gaughen JR, Jensen ME, Schweickert PA, Kauf¬mann TJ, Marx WF, Kallmes DF. Relevance of ante¬cedent venography in percutaneous vertebroplasty for the treatment of osteoporotic compression fractures. American Journal of Neuroradiology. 2002;23(4):594-600. Available from: http://www.ajnr.org/content/23/4/594.long

Zhan Yi, Jiang Jianzhong, Liao Haifen, Tan Haitao, Yang Keqin. Risk factors for cement leakage after vertebroplasty or kyphoplasty: A meta-analysis of published evidence. World Neurosurgery. 2017;101:633-42. doi: https://doi.org/10.1016/j.wneu.2017.01.124

Sakae Tanaka. Molecular understanding of pharmacological treatment of osteoporosis. Efort Open Rev. 2019;4:158-64. doi: https://doi.org/10.1302/2058-5241.4.180018

Wang G, Sui L, Gai P, Li G, Qi X, Jiang X. The efficacy and safety of vertebral fracture prevention therapies in postmenopausal osteoporosis treatment. Bone Joint Res. 2017;6:452-63. doi: https://doi.org/10.1302/2046-3758.67

Published

2021-03-26

How to Cite

1.
Stashkevych A, Shevchuk A, Uleshchenko D, Martynenko V, Melenko V. Dynamics of pain syndrome and quality of life in the application of vertebroplasty in patients with vertebral fractures against osteoporosis. Med. perspekt. [Internet]. 2021Mar.26 [cited 2024Jul.24];26(1):169-75. Available from: https://journals.uran.ua/index.php/2307-0404/article/view/227996

Issue

Section

CLINICAL MEDICINE